Clinical trials are vital to improving treatments for any cancer, but are especially important for rare sarcomas. For instance, treatment advances through clinical studies have provided effective alternatives to amputation of a limb — previously a primary form of treatment for sarcomas.
Recent trials have examined minimizing side effects and maximizing outcomes for patients undergoing radiation therapy. Our sarcoma experts also focus on innovative medical therapies for patients who are experiencing recurrence. The Sarcoma Program participates in significant, multi-institutional studies through membership in such groups as the NRG Oncology, Sarcoma Alliance for Research Through Collaboration and the National Cancer Institute.
Virtual Visits Are Available
Safe and convenient virtual visits by video let you get the care you need via a mobile device, tablet or computer wherever you are. We’ll gather your medical records for you and get our experts’ input so we can offer treatment options without an in-person visit. To schedule a virtual visit, call 1-866-680-0505.
Cancer and the COVID-19 Vaccine
There is currently no data that suggests current or former cancer patients should avoid getting the COVID-19 vaccine. Cancer can weaken your immune system, so we recommend that most patients get the vaccine as soon as possible.
Nationally Ranked by U.S. News & World Report
Froedtert Hospital is nationally ranked in three adult specialties by U.S. News & World Report, including rehabilitation. Froedtert Hospital is also recognized as high performing in four adult specialties and 15 procedures and conditions, including orthopaedics.More to Explore
